Bleakley Financial Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Bleakley Financial Group's EXAS Position: Q4 2023 in Review
Bleakley Financial Group sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 3,010 shares — an estimated $205K sold.
Bleakley Financial Group first reported a position in EXAS in Q2 2023 and held it in 2 quarters. The position peaked at $272K in Q2 2023. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.
- Bleakley Financial Group reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
- Bleakley Financial Group sold 3,010 Exact Sciences shares in Q4 2023, an estimated $205K.
- Bleakley Financial Group first reported a position in Exact Sciences in Q2 2023 and held it in 2 quarters.
- Bleakley Financial Group's Exact Sciences position peaked at $272K in Q2 2023.
- 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.
Based on Bleakley Financial Group's 13F filing for Q4 2023, filed 25 Jan 2024.